
Insulet Corp
PODD · Healthcare · Health Care
Updated 25 min ago · data delayed ≥15 min
Iconic Score
ProprietaryRanked #454 of 503 by Iconic Score · #55 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a blend of scale, market attention, and category leadership.
Iconic Profile
Insulet Corporation (PODD) is a leading medical device company specializing in innovative insulin delivery systems for individuals with diabetes. Its flagship product, the Omnipod Insulin Management System, offers a tubeless, waterproof insulin pump that enhances patient convenience and adherence to therapy. With a market capitalization of $11.3 billion, Insulet has established a strong position within the healthcare sector by focusing on technology-driven solutions that improve the quality of life for diabetes patients. The company's commitment to continuous innovation and expansion into new markets underscores its significance in addressing the growing global diabetes epidemic. As the demand for advanced diabetes management solutions rises, Insulet's role in providing effective and user-friendly products positions it as a key player in the healthcare landscape.
Enterprise tier: claim your logo to manage how your brand is represented.